Avivit Cahn
Brigham and Women's Hospital
1 paper in the Anchorcite directory, published in 2018, cited 6,600 times in total.
ORCID profileResearch topics
- Diabetes Treatment and Management · 1 paper
- Chronic Kidney Disease and Diabetes · 1 paper
- Heart Failure Treatment and Management · 1 paper
Frequent co-authors
- Stephen D. Wiviott · 1 paper
- Itamar Raz · 1 paper
- Marc P. Bonaca · 1 paper
- Ofri Mosenzon · 1 paper
- Eri Toda Kato · 1 paper
- Michael G. Silverman · 1 paper
- Thomas A. Zelniker · 1 paper
- Julia Kuder · 1 paper
Papers
- Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesNew England Journal of Medicine · 2018 · 6,600 citations
BACKGROUND: The cardiovascular safety profile of dapagliflozin, a selective inhibitor of sodium-glucose cotransporter 2 that promotes glucosuria in patients with type 2 diabetes, is undefined. METHODS: of body-surface area, new end-stage renal disease, or death from renal or cardiovascular causes)…
Metadata from OpenAlex (CC0).